CELLULAR BIOMEDICINE GROUP I's ticker is CBMG and the CUSIP is 15117P102. A total of 76 filers reported holding CELLULAR BIOMEDICINE GROUP I in Q3 2020. The put-call ratio across all filers is 2.38 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $237,000 | 0.0% | 12,900 | 0.0% | 0.00% | – |
| Q3 2020 | $237,000 | +22.8% | 12,900 | 0.0% | 0.00% | – |
| Q2 2020 | $193,000 | -5.4% | 12,900 | 0.0% | 0.00% | – |
| Q1 2020 | $204,000 | -2.4% | 12,900 | 0.0% | 0.00% | – |
| Q4 2019 | $209,000 | +8.9% | 12,900 | 0.0% | 0.00% | – |
| Q3 2019 | $192,000 | -9.9% | 12,900 | 0.0% | 0.00% | – |
| Q2 2019 | $213,000 | -4.5% | 12,900 | 0.0% | 0.00% | – |
| Q1 2019 | $223,000 | -2.2% | 12,900 | 0.0% | 0.00% | – |
| Q4 2018 | $228,000 | -2.6% | 12,900 | 0.0% | 0.00% | – |
| Q3 2018 | $234,000 | -7.1% | 12,900 | 0.0% | 0.00% | – |
| Q2 2018 | $252,000 | +86.7% | 12,900 | +13.1% | 0.00% | – |
| Q1 2017 | $135,000 | -9.4% | 11,407 | +0.0% | 0.00% | – |
| Q4 2016 | $149,000 | -9.7% | 11,406 | 0.0% | 0.00% | – |
| Q3 2016 | $165,000 | +52.8% | 11,406 | +26.7% | 0.00% | – |
| Q2 2016 | $108,000 | -35.7% | 9,000 | 0.0% | 0.00% | – |
| Q1 2016 | $168,000 | -13.0% | 9,000 | 0.0% | 0.00% | – |
| Q4 2015 | $193,000 | +27.0% | 9,000 | 0.0% | 0.00% | – |
| Q3 2015 | $152,000 | -35.9% | 9,000 | +42.2% | 0.00% | – |
| Q2 2015 | $237,000 | – | 6,330 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|